See also this year's filing and all EDGAR filings for this company.
PDF Report 0001668243_2022_UroGen_Pharma_Ltd.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 3.1051991150442477, 'aggregate_val': 111333000, 'exp_sum': 27120000, 'exp_to_value': {'LiabilitiesCurrent': 22380000, 'LiabilitiesNoncurrent': 398000, 'remainder_Liabilities': 4342000}} |
Graph
Absolute values for 0001668243, UroGen Pharma Ltd.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 114,390,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,967,000 |
| 3 | remainder_Assets | 3,389,000 |
| 4 | LiabilitiesCurrent | 22,380,000 |
| 5 | LiabilitiesNoncurrent | 398,000 |
| 6 | remainder_Liabilities | 88,555,000 |
| 7 | CostOfGoodsAndServicesSold | 5,157,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 87,535,000 |
| 9 | ResearchAndDevelopmentExpense | 47,642,000 |
| 10 | remainder_Expenses | 18,740,000 |
| 11 | remainder_Revenues | 48,042,000 |
| 12 | remainder_NetIncome | 212,000 |
| 13 | remainder_ComprehensiveNetIncome | -296,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 119,746,000 |
| 1 | Liabilities | 111,333,000 |
| 2 | Expenses | 159,074,000 |
| 3 | Revenues | 48,042,000 |
| 4 | StockholdersEquity | 8,413,000 |
| 5 | NetIncome | -110,820,000 |
| 6 | ComprehensiveNetIncome | -110,968,000 |
| 7 | BaseVar | 219,351,500 |
| 8 | EconomicCapitalRatio | -0.835 |
Edgar->Model Mapping
Feature Distribution
Change over Time
